Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-22

Clinical Trial Update: L-DOPA vs. Placebo for Depression and Psychomotor Slowing in Older Adults [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating L-DOPA versus placebo for depression and psychomotor slowing in older adults has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-Dopa (Levodopa)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Major Depressive Disorder, Dysthymia | Phase 4 | Status: TERMINATED | Results posted: 2023-05-22